Abstract
MYH2-associated myopathy is a group of congenital heterogeneous diseases. Case reports with MYH2-associated myopathy due to compound heterozygous mutations are rare. We report a 63-year-old Asian female who presented with bilateral ptosis and limb weakness for over 10 years. The orbits magnetic resonance imaging showed no abnormalities. Muscle biopsy revealed characteristics consistent with congenital neuromuscular disease with uniform type 1 fibers. Genetic testing identified compound heterozygous mutations in the MYH2 gene: a heterozygous mutation in exon 30, c.4066G>T (chr17:10430037, p.E1356X) and a heterozygous mutation in exon 38, c.5473-1G>A (chr17:10426730, splicing). The novel gene mutations are considered potential pathogenic variants. MYH2-associated myopathy was diagnosed. Following treatment with cytidine diphosphate choline, coenzyme Q10, methylcobalamin, and idebenone, her ocular symptoms showed slight improvement before discharge. This case highlights the importance of genetic testing in diagnosing rare myopathies and expands the genetic spectrum of MYH2-associated myopathy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Data availability
The data supporting this study’s findings are available from the corresponding author [Lu Guo] upon reasonable request.
References
Morales PN, Coons AN, Koopman AJ, Patel S, Chase PB, Parvatiyar MS, et al. Post-translational modifications of vertebrate striated muscle myosin heavy chains. Cytoskeleton. 2024;81:832–42.
Xu WM, Gorman PA, Rider SH, Hedge PJ, Moore G, Prichard C, et al. Construction of a genetic map of human chromosome 17 by use of chromosome-mediated gene transfer. Proc Natl Acad Sci USA. 1988;85:8563–7.
Martinsson T, Darin N, Kyllerman M, Oldfors A, Hallberg B, Wahlström J. Dominant hereditary inclusion-body myopathy gene (IBM3) maps to chromosome region 17p13.1. Am J Hum Genet. 1999;64:1420–6.
Findlay AR, Harms MB, Pestronk A, Weihl CC. Homozygous recessive MYH2 mutation mimicking dominant MYH2 associated myopathy. Neuromuscul Disord. 2018;28:675–9.
Cabrera-Serrano M, Fabian VA, Boutilier J, Wise C, Faiz F, Lamont PJ, et al. Adult onset distal and proximal myopathy with complete ophthalmoplegia associated with a novel de novo p.(Leu1877Pro) mutation in MYH2. Clin Genet. 2015;88:573–8.
Baskar D, Vengalil S, Nashi S, Bardhan M, Srivastava K, Sanka SB, et al. MYH2-related myopathy: expanding the clinical spectrum of chronic progressive external ophthalmoplegia (CPEO). J Neuromuscul Dis. 2023;10:727–30.
Telese R, Pagliarani S, Lerario A, Ciscato P, Fagiolari G, Cassandrini D, et al. MYH2 myopathy, a new case expands the clinical and pathological spectrum of the recessive form. Mol Genet Genom Med. 2020;8:e1320.
Sonne A, Peverelli L, Hernandez-Lain A, DomÃnguez-González C, Andersen JL, Milone M, et al. Myosin post-translational modifications and function in the presence of myopathy-linked truncating MYH2 mutations. Am J Physiol Cell Physiol. 2023;324:C769–C76.
Tajsharghi H, Thornell LE, Darin N, Martinsson T, Kyllerman M, Wahlström J, et al. Myosin heavy chain IIa gene mutation E706K is pathogenic and its expression increases with age. Neurology. 2002;58:780–6.
Tajsharghi H, Darin N, Rekabdar E, Kyllerman M, Wahlström J, Martinsson T, et al. Mutations and sequence variation in the human myosin heavy chain IIa gene (MYH2). Eur J Hum Genet. 2005;13:617–22.
Lossos A, Baala L, Soffer D, Averbuch-Heller L, Dotan S, Munnich A, et al. A novel autosomal recessive myopathy with external ophthalmoplegia linked to chromosome 17p13.1-p12. Brain. 2005;128:42–51.
Tajsharghi H, Hilton-Jones D, Raheem O, Saukkonen AM, Oldfors A, Udd B. Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations. Brain. 2010;133:1451–9.
D’Amico A, Fattori F, Bellacchio E, Catteruccia M, Servidei S, Bertini E. A new de novo missense mutation in MYH2 expands clinical and genetic findings in hereditary myosin myopathies. Neuromuscul Disord. 2013;23:437–40.
Hernández-LaÃn A, Esteban-Pérez J, Montenegro DC, DomÃnguez-González C. Myosin myopathy with external ophthalmoplegia associated with a novel homozygous mutation in MYH2. Muscle Nerve 2017;55:E8–E10.
Chen N, Shen N, Yu Y, Chen C, Li X, Liang J, et al. Clinical remission of myopathy with MYH2 deficiency after precision medicine-developed rehabilitation: a case report. Am J Transl Res. 2018;10:3827–32.
Argov Z. Neuromuscular disorders in Israel: a model country for ethnic clusters. Neuromuscul Disord. 2019;29:269–73.
Madigan NN, Polzin MJ, Cui G, Liewluck T, Alsharabati MH, Klein CJ, et al. Filamentous tangles with nemaline rods in MYH2 myopathy: a novel phenotype. Acta Neuropathol Commun. 2021;9:79.
Hedberg-Oldfors C, ElÃasdóttir Ó, Geijer M, Lindberg C, Oldfors A. Dominantly inherited myosin IIa myopathy caused by aberrant splicing of MYH2. BMC Neurol. 2022;22:428.
Carrington G, Hau A, Kosta S, Dugdale HF, Muntoni F, D’Amico A, et al. Human skeletal myopathy myosin mutations disrupt myosin head sequestration. JCI Insight 2023;8:e172322.
Cassini TA, Malicdan MCV, Macnamara EF, Lehky T, Horkayne-Szakaly I, Huang Y, et al. MYH2-associated myopathy caused by a novel splice-site variant. Neuromuscul Disord. 2023;33:257–62.
Oh SJ, Danon MJ. Nonprogressive congenital neuromuscular disease with uniform type 1 fiber. Arch Neurol. 1983;40:147–50.
Pellegrini G, Barbieri S, Moggio M, Cheldi A, Scarlato G, Minetti C. A case of congenital neuromuscular disease with uniform type I fibers, abnormal mitochondrial network and jagged Z-line. Neuropediatrics. 1985;16:162–6.
Takeda S, Horigome K, Nakadai A, Oguchi K, Yanagisawa N. A case of nemaline myopathy with uniform type I fiber and unique hybrid pattern of myosin light chains. Rinsho Shinkeigaku. 1986;26:119–27.
Jong YJ, Huang SC, Liu GC, Chiang CH. Mental retardation in congenital nonprogressive myopathy with uniform type 1 fibers. Brain Dev. 1991;13:444–6.
Araki A, Kurokawa T, Sakuragawa N, Nonaka I. Congenital neuromuscular disease with uniform type 1 fibers : a case report. No Hattatsu. 1991;23:295–8.
Jung EY, Hattori H, Higuchi Y, Mitsuyoshi I, Kanda T. Brain atrophy in congenital neuromuscular disease with uniform type 1 fibers. Pediatr Neurol. 1997;16:56–8.
Tojo M, Ozawa M, Nonaka I. Central core disease and congenital neuromuscular disease with uniform type 1 fibers in one family. Brain Dev. 2000;22:262–4.
Sewry CA, Müller C, Davis M, Dwyer JSM, Dove J, Evans G, et al. The spectrum of pathology in central core disease. Neuromuscul Disord. 2002;12:930–8.
Na S-J, Kang S-W, Lee K-O, Lee K-Y, Kim T-S, Choi Y-C. A case of congenital neuromuscular disease with uniform type 1 fiber. Yonsei Med J. 2004;45:150–2.
Rakocevic-Stojanovic V, Lavrnic D, Nestorovic B, Dozic S, Cvetkovic D. Congenital myopathy with uniform type 1 fibers. Acta Myol. 2005;24:162–3.
Sakamoto HM, Yoshioka M, Tsuji M, Kuroki S, Higuchi Y, Nonaka I, et al. A case of congenital neuromuscular disease with uniform type 1 fibers. Brain Dev. 2006;28:202–5.
Sato I, Wu S, Ibarra MCA, Hayashi YK, Fujita H, Tojo M, et al. Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation. Neurology. 2008;70:114–22.
Okutani R, Arashi D, Tsujii K. Anesthetic case in a child with congenital neuromuscular disease with uniform type 1 fibers (CNMDU1). J Anesth. 2010;24:797–800.
Haraki T, Yasuda T, Mukaida K, Migita T, Hamada H, Kawamoto M. Mutated p.4894 RyR1 function related to malignant hyperthermia and congenital neuromuscular disease with uniform type 1 fiber (CNMDU1). Anesth Analg. 2011;113:1461–7.
Imagama S, Kawakami N, Tsuji T, Ohara T, Ishiguro N. Kyphoscoliosis associated with congenital neuromuscular disease with uniform type 1 fibers. Eur Spine J. 2012;21:S499–S504.
Sanmaneechai O, Likasitwattanakul S, Sangruchi T, Nishino I. Ophthalmoplegia in congenital neuromuscular disease with uniform type 1 fiber. Brain Dev. 2015;37:459–62.
Acknowledgements
This work is supported by the Key Clinical Specialty of Neurology of PLA to Daping Hospital.
Funding
This study was supported by the Natural Science Foundation Project of CQ CSTC (cstc2019jscx-msxmX0285) and the Natural Science Foundation Project of Chongqing (CSTB2022NSCQ-MSX1585).
Author information
Authors and Affiliations
Contributions
Yulai Kang, Tong Yang and Xue Chen wrote the manuscript. Zhuo Min and Chunhua Tang diagnosed, treated, and followed the patient. Lili Zhang and Lu Guo conceived the study and revised it critically for important intellectual content. All authors read and approved the final version of the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
This study was exempted from ethical applications by the ethics committee of the Army Medical Centre of PLA. Written informed consent was obtained from the patient.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Kang, Y., Yang, T., Chen, X. et al. MYH2-associated myopathy caused by novel compound heterozygous mutations: a case report and literature review. J Hum Genet 70, 655–659 (2025). https://doi.org/10.1038/s10038-025-01400-7
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s10038-025-01400-7